267 related articles for article (PubMed ID: 2807914)
1. [Increased incidence of multiple melanoma in sporadic and familial dysplastic nevus cell syndrome].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Sep; 40(9):548-52. PubMed ID: 2807914
[TBL] [Abstract][Full Text] [Related]
2. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
Szekeres L; Korom I
Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
[TBL] [Abstract][Full Text] [Related]
3. Multiple primary melanoma: epidemiological and prognostic implications; analysis of 36 cases.
Buljan M; Situm M; Bolanca Z; Zivković MV; Mihić LL
Coll Antropol; 2010 Apr; 34 Suppl 2():131-4. PubMed ID: 21302712
[TBL] [Abstract][Full Text] [Related]
4. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study.
Marghoob AA; Kopf AW; Rigel DS; Bart RS; Friedman RJ; Yadav S; Abadir M; Sanfilippo L; Silverman MK; Vossaert KA
Arch Dermatol; 1994 Aug; 130(8):993-8. PubMed ID: 8053716
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
Schneider JS; Moore DH; Sagebiel RW
Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
[TBL] [Abstract][Full Text] [Related]
6. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
7. [Connection between uveal melanoma and dysplastic naevus syndrome].
Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
[TBL] [Abstract][Full Text] [Related]
8. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
[TBL] [Abstract][Full Text] [Related]
9. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
[TBL] [Abstract][Full Text] [Related]
10. Multiple primary melanoma revisited.
Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
[TBL] [Abstract][Full Text] [Related]
11. Five cases of coexistent primary ocular and cutaneous melanoma.
Bataille V; Pinney E; Hungerford JL; Cuzick J; Bishop DT; Newton JA
Arch Dermatol; 1993 Feb; 129(2):198-201. PubMed ID: 8434978
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
[TBL] [Abstract][Full Text] [Related]
14. Dysplastic nevi and other risk markers for melanoma.
Seykora J; Elder D
Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
[TBL] [Abstract][Full Text] [Related]
15. [Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra].
Bergman W; van Voorst Vader PC; Ruiter DJ
Ned Tijdschr Geneeskd; 1997 Oct; 141(42):2010-4. PubMed ID: 9550752
[TBL] [Abstract][Full Text] [Related]
16. [Which malignant melanomas are genetically determined?].
Sigg C; Schnyder UW
Hautarzt; 1988 Jul; 39(7):409-12. PubMed ID: 3065287
[TBL] [Abstract][Full Text] [Related]
17. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
18. From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients.
de Snoo FA; Kroon MW; Bergman W; ter Huurne JA; Houwing-Duistermaat JJ; van Mourik L; Snels DG; Breuning MH; Willemze R; Frants RR; Gruis NA
J Am Acad Dermatol; 2007 May; 56(5):748-52. PubMed ID: 17276542
[TBL] [Abstract][Full Text] [Related]
19. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
Sato K; Howell JN; Greene MH; Maher VM; McCormick JJ
Cancer Res; 1988 Sep; 48(18):5145-50. PubMed ID: 3136916
[TBL] [Abstract][Full Text] [Related]
20. [Dysplastic nevus syndrome with familial melanoma (type D2)].
Casanova JM; Panadés MJ; Ramos J; Salvatella N
Med Clin (Barc); 1989 Mar; 92(10):382-4. PubMed ID: 2716387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
